If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
80.90    -3.80 (-4.49%)
Bid:
81.50
Ask:
82.30
Spread: 0.80 (0.982%)
Market Cap: £132.63m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Q1 Trading update

26 Apr 2018 07:00

RNS Number : 1543M
Synthomer PLC
26 April 2018
 

April 26th 2018

Synthomer plc

Q1 Trading update

Solid Q1 performance in line with expectations; 2018 outlook unchanged

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the first quarter ended March 31st, 2018.

Trading

Europe and North America

The Europe and North America segment delivered another solid performance. Volumes were higher than the comparative period predominantly reflecting the positive impact of the Speciality Additives and Pischelsdorf SBR latex acquisitions. Unit margins were marginally lower mainly due to the transactional impact of European sales denominated in US dollars.

Asia and Rest of World

The Asia and Rest of World segment remained stable with performance in line with our expectations. Nitrile latex volumes were marginally higher than a weaker comparative period when customer spending was impacted by the volatile raw material environment. Unit margins were broadly in line with Q1 2017. We remain cautiously optimistic on the continued Nitrile latex demand growth and margin development recognising that our 90kt capacity is on track to come on line in late Q3 2018.

Financial Position

Net debt increased from £180m at the year end to £246m at 31 March 2018. This reflected completion of the acquisition of the BASF Austrian SBR business and assets in Pischelsdorf for €29m (£25m) in January and seasonal working capital movements which was, as we saw in 2017, impacted by a rising raw material price environment.

2018 outlook unchanged

Overall, the Group continues to trade in line with the Board's expectations, and accordingly the view for Full Year 2018 remains unchanged.

-ENDS-

 

ENQUIRIES:

Calum MacLean, Chief Executive Officer

Charles Armitstead

Stephen Bennett, Chief Financial Officer

Teneo

Tel: + 44 1279 436211

Tel: + 44 20 3603 5220

 

The Company will hold a conference call for investors and analysts at 0800 BST today. 

Please dial 0800 3589473 PIN: 92017967# to gain access to the call.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFKPDKCBKDCQB
Date   Source Headline
28th Jun 20101:18 pmRNSDirectorate Change
24th Jun 20107:00 amRNSPre-close Trading Update
2nd Jun 20108:54 amRNSCompletion of disposal
6th May 201012:32 pmRNSResult of AGM
6th May 201011:00 amRNSInterim Management Statement
30th Apr 201012:40 pmRNSAnnual Information Update
8th Apr 20107:00 amRNSAnnual Financial Report
12th Mar 20107:00 amRNSDisposal
11th Mar 201010:32 amRNSDirector/PDMR Shareholding
11th Mar 201010:31 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSFinal Results
11th Feb 201012:32 pmRNSHolding(s) in Company
4th Feb 201011:38 amRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Update
25th Nov 200910:02 amRNSHolding(s) in Company
18th Nov 20099:28 amRNSHolding(s) in Company
19th Oct 20097:00 amRNSInterim Management Statement
2nd Sep 200910:14 amRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
23rd Jun 20097:00 amRNSPre-close Trading Update
18th May 20099:16 amRNSDirector/PDMR Shareholding
14th May 200912:40 pmRNSResult of AGM
14th May 20097:00 amRNSAGM & Interim Management Statement
1st May 20097:00 amRNSAppointment of new joint brokers
21st Apr 20094:20 pmRNSAnnual Information Update
15th Apr 20099:24 amRNSAnnual Financial Report
23rd Mar 20094:03 pmRNSHolding(s) in Company
23rd Mar 20094:01 pmRNSHolding(s) in Company
20th Mar 200910:31 amRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSAppointment of Senior Independent Director
16th Mar 20094:54 pmRNSDirector/PDMR Shareholding
12th Mar 20092:35 pmRNSDirector/PDMR Shareholding
12th Mar 20092:31 pmRNSDirector/PDMR Shareholding
11th Mar 20094:18 pmRNSDirector/PDMR Shareholding
11th Mar 20097:00 amRNSFinal Results
4th Mar 20094:35 pmRNSPrice Monitoring Extension
4th Mar 20091:57 pmRNSAppointment of non-executive director
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
30th Jan 20093:54 pmRNSNew Loan Facility / Completion of Disposal
21st Jan 20097:00 amRNSAppointment of new Chairman
19th Jan 20094:29 pmRNSDirector/PDMR Shareholding
15th Jan 20091:59 pmRNSDirector/PDMR Shareholding
13th Jan 200912:33 pmRNSHolding(s) in Company
7th Jan 20095:29 pmRNSDirector/PDMR Shareholding
5th Jan 200911:17 amRNSDisposal
29th Dec 20087:00 amRNSUpdate
12th Dec 200810:08 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSSale of PFW Aroma Chemicals BV
3rd Dec 200810:57 amRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.